Goldman Sachs has initiated coverage of large-cap life sciences tools companies, naming Agilent (A), Danaher (DHR), and Thermo Fisher Scientific (TMO) as buys. The investment bank set a price target ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results